All news from Anaesthesiology

Ivosidenib Approved To Treat AML With IDH1 Mutation

Ivosidenib, an oral, targeted inhibitor of the IDH1 enzyme, is the first and only FDA-approved therapy for patients with R/R AML and an IDH1 mutation. Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the U.S. Food and Drug Administration

Study On Bladder Self Repairment

The bladder is a master at self-repair. When damaged by infection or injury, the organ can mend itself quickly, calling upon specialized cells in its lining to repair tissue and restore a barrier against harmful materials concentrated in urine

New Approaches in Regenerative Medicine and Tumor Therapy

Scientists have long known that organ size is shaped by many factors, including the size of each cell, proliferation, cell differentiation, death, and, of course, the total number of cells. However, the molecular mechanisms directly regulating organ size had until now remained elusive, setting the stage for the current research directed by Assistant Professor Yaron Fuchs and led by Dr. Yahav Yosefzon.

Research Reveals Facts Concerning Working Memory in Children

Researchers from the Higher School of Economics conducted a meta-analysis in which they compiled data across 17 neuroimaging studies on working memory in children. The data shows concordance in frontoparietal regions recognized for their role in working memory as well as regions not typically highlighted as part of the working memory network, such as the insula

Activating circadian clock kills cancer cells

A recent study found that women who work night shifts have substantially higher risks of breast, digestive system, and skin cancers. The findings reinforced a connection researchers have observed between cancer and the circadian clock, a biological system that controls the daily schedule of physiological processes.

Now, in findings that could lead to a new class of cancer drugs, researchers have uncovered details about a key molecular link between circadian rhythm and cancer.